Caricamento...
Updates on mechanism of action and clinical efficacy of risedronate in osteoporosis
Risedronate is a heterocyclic orally active aminobisphosphonate and it belongs to the bisphosphonate category: these drugs are powerful bone resorption inhibitors, thanks to their affinity for hydroxyapatite crystals at bone mineral matrix level and to their inhibiting effects on osteoclast activity...
Salvato in:
| Pubblicato in: | Clin Cases Miner Bone Metab |
|---|---|
| Autore principale: | |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
CIC Edizioni Internazionali
2014
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4269145/ https://ncbi.nlm.nih.gov/pubmed/25568655 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|